Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca
Go back to Medicus Pharma Announces SkinJect® Phase 2 Principal Investigator and Key Opinion Leader (KOL), Babar K. Rao MD, FAAD, to Provide Clinical Interpretation of Positive Data During Business Update Webca| (NASDAQ: MDCX) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $ | |||
| Open | $0.43 | 52 Week Low | $ | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $ | |||
| Volume | 13,163 | |||||
| (NASDAQ: MDCX) | Delayed: 0.43 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.43 | 52 Week High | $ | |||
| Open | $0.43 | 52 Week Low | $ | |||
| Day High | $0.43 | P/E | N/A | |||
| Day Low | $0.43 | EPS | $ | |||
| Volume | 13,163 | |||||

